Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 4
2009 1
2010 4
2011 9
2012 5
2013 4
2014 7
2015 4
2016 2
2017 4
2018 2
2020 4
2021 2
2022 10
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants.
Yu H, Liu B, Zhang Y, Gao X, Wang Q, Xiang H, Peng X, Xie C, Wang Y, Hu P, Shi J, Shi Q, Zheng P, Feng C, Tang G, Liu X, Guo L, Lin X, Li J, Liu C, Huang Y, Yang N, Chen Q, Li Z, Su M, Yan Q, Pei R, Chen X, Liu L, Hu F, Liang D, Ke B, Ke C, Li F, He J, Wang M, Chen L, Xiong X, Tang X. Yu H, et al. Among authors: ke b. Nat Commun. 2023 Feb 24;14(1):1058. doi: 10.1038/s41467-023-36761-0. Nat Commun. 2023. PMID: 36828833 Free PMC article.
Comparison of model-specific histopathology in mouse models of COVID-19.
Yang S, Cao L, Xu W, Xu T, Zheng B, Ji Y, Huang S, Liu L, Du J, Peng H, Zhang H, Chen J, Ke B, Zheng H, Deng X, Li C, Guo D. Yang S, et al. Among authors: ke b. J Med Virol. 2022 Aug;94(8):3605-3612. doi: 10.1002/jmv.27747. Epub 2022 Apr 13. J Med Virol. 2022. PMID: 35355296 Free PMC article.
The immunodominant and neutralization linear epitopes for SARS-CoV-2.
Lu S, Xie XX, Zhao L, Wang B, Zhu J, Yang TR, Yang GW, Ji M, Lv CP, Xue J, Dai EH, Fu XM, Liu DQ, Zhang L, Hou SJ, Yu XL, Wang YL, Gao HX, Shi XH, Ke CW, Ke BX, Jiang CG, Liu RT. Lu S, et al. Cell Rep. 2021 Jan 26;34(4):108666. doi: 10.1016/j.celrep.2020.108666. Cell Rep. 2021. PMID: 33503420 Free PMC article.
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants.
Liao G, Lau H, Liu Z, Li C, Xu Z, Qi X, Zhang Y, Feng Q, Li R, Deng X, Li Y, Zhu Q, Zhu S, Zhou H, Pan H, Fan X, Li Y, Li D, Chen L, Ke B, Cong Z, Lv Q, Liu J, Liang D, Li A, Hong W, Bao L, Zhou F, Gao H, Liang S, Huang B, Wu M, Qin C, Ke C, Liu L. Liao G, et al. Among authors: ke b. Virol J. 2022 Dec 9;19(1):212. doi: 10.1186/s12985-022-01940-w. Virol J. 2022. PMID: 36494863 Free PMC article.
The kinetics of viral load and antibodies to SARS-CoV-2.
Sun J, Tang X, Bai R, Liang C, Zeng L, Lin H, Yuan R, Zhou P, Huang X, Xiong Q, Peng J, Cui F, Ke B, Su J, Liu Z, Lu J, Tian J, Sun R, Ke C. Sun J, et al. Among authors: ke b. Clin Microbiol Infect. 2020 Dec;26(12):1690.e1-1690.e4. doi: 10.1016/j.cmi.2020.08.043. Epub 2020 Sep 6. Clin Microbiol Infect. 2020. PMID: 32898715 Free PMC article.
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants.
Cao L, Li Y, Yang S, Li G, Zhou Q, Sun J, Xu T, Yang Y, Liao R, Shi Y, Yang Y, Zhu T, Huang S, Ji Y, Cong F, Luo Y, Zhu Y, Luan H, Zhang H, Chen J, Liu X, Luo R, Liu L, Wang P, Yu Y, Xing F, Ke B, Zheng H, Deng X, Zhang W, Lin C, Shi M, Li CM, Zhang Y, Zhang L, Dai J, Lu H, Zhao J, Zhang X, Guo D. Cao L, et al. Among authors: ke b. Sci Transl Med. 2022 Sep 7;14(661):eabm7621. doi: 10.1126/scitranslmed.abm7621. Epub 2022 Sep 7. Sci Transl Med. 2022. PMID: 35579533 Free PMC article.
66 results